CANnabinoids in Pediatric ONCology

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Childhood CancerCancer
Interventions
DRUG

MPL-001

High-CBD arm (MPL-001) a cannabidiol-enriched cannabis herbal extract which contains a 1:25 ratio of THC:CBD. The MPL-001 oil is produced by MediPharm Labs, each ml contains 50mg CBD and 2mg THC.

DRUG

MPL-005

Medium-CBD arm (MPL-005) a cannabidiol-enriched cannabis herbal extract which contains a 1:5 ratio of THC:CBD. The MPL-005 oil is produced by MediPharm Labs, each ml contains 25mg CBD and 5mg THC.

DRUG

MPL-009

Balanced arm (MPL-009) a balanced 1:1 ratio of THC:CBD. The MPL-009 oil is produced by MediPharm Labs, each ml contains 25mg CBD and 25mg THC.

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Manitoba

OTHER